Koneksa, the developer of a digital mobile biomarker platform that captures, monitors, and analyzes patient-generated data and outcomes in clinical studies, announced the completion of a
![Koneksa Closes $16 Million to Expand Digital Biomarker Platform](https://mercomcapital.com/wp-content/uploads/2020/09/Mercom-38.png)
Koneksa, the developer of a digital mobile biomarker platform that captures, monitors, and analyzes patient-generated data and outcomes in clinical studies, announced the completion of a